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Abstract: Background
The role of radiographs in the follow-up of metal-on-metal hip resurfacing (MoMHR)
patients is unclear. We investigated whether a combination of patient and radiological
factors predicted MoMHRs with evidence of a pseudotumour.
Methods
We performed a retrospective single-centre case-control study (384 MoMHRs). The
pseudotumour group (n=130) all had symptomatic pseudotumours on cross-sectional
imaging with the diagnosis confirmed at revision. The non-pseudotumour group
(n=254; subgroup previously reported on) had normal cross-sectional imaging.
Radiographs immediately prior to revision were assessed in the pseudotumour group
and compared with radiographs performed at the time of normal cross-sectional
imaging in the non-pseudotumour group. Two blinded independent observers analysed
radiographs for signs of failure (excellent inter-observer agreement). Logistic
regression modeling identified patient and radiological predictors of pseudotumour
revision.
Results
Pseudotumour hips more commonly had abnormal radiographs (80.0% vs. 63.4%;
p=0.001). Patient and radiological factors predicting pseudotumour revision in the
multivariable model were: female gender (odds ratio (OR) 3.14 (95% CI 1.85-5.35);
p<0.001), high inclination (OR 1.04 per degree (95% CI 1.01-1.07); p=0.006),
acetabular osteolysis (OR 5.06 (95% CI 2.14-12.0); p<0.001), femoral osteolysis (OR
17.8 (95% CI 5.09-62.2); p<0.001), and acetabular loosening (OR 3.35 (95% CI 1.34-
8.35); p=0.009). Factors predicting being in the non-pseudotumour group were:
anteversion >5o (5o to <10o: OR 0.31 (95% CI 0.12-0.77), p=0.012; >10o: OR=0.32
(95% CI 0.15-0.70), p=0.004) and heterotopic ossification (OR 0.19 (95% CI 0.05-
0.72); p=0.015). The model was well calibrated (p=0.589) with good discriminatory
ability (area under the curve (AUC)=0.801; sensitivity=74.4%, specificity=71.7%).
Conclusions
A combination of patient and radiological factors provided useful information for
distinguishing between MoMHRs with and without evidence of pseudotumours.
Surgeons may wish to consider these specific patient and radiological factors before
proceeding with cross-sectional imaging. Radiographs are important when assessing
MoMHR patients and should be included in all follow-up protocols.
Level of Evidence
Diagnostic Study (Level III)
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definition for pseudotumour was used: (1) cystic, solid, or mixed masses communicating with 
the hip joint (n=130), or (2) significant metallosis, synovitis, tissue damage and/or necrosis in 
the absence of mass lesions (n=5).4,5,17,21,22 The diagnosis of a pseudotumour was 
confirmed if there was also histological evidence of lymphocytic infiltrates (including aseptic 
lymphocytic vasculitis and associated lesions) and a phagocytic macrophage response to 
metal wear debris, with or without tissue necrosis.23-25" 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that the diagnosis of a pseudotumor was confirmed by lymphocyte infiltrates and a 
phagocytic macrophage response to debris. So this to me indicates they are including 
ALVAL cases without mass lesions (they cite the Willert article to support their definition, 
although as I recall, the term "pseudotumor" was never used in the Willert publication). 
Incidentally, just because the authors may be able to cite prior work that may have also 
included "non-mass pseudotumors" doesn't mean they should perpetuate sloppy 
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of lymphocytic infiltrates (including aseptic lymphocytic vasculitis and associated lesions) 
and a phagocytic macrophage response to metal wear debris" were excluded (in other words, 
according to the authors' definition any case with ALVAL histology would have to be 
considered pseudotumor cases). Buy why not just limit the pseudotumor group to those 130 
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Can patient and radiological factors predict metal-on-metal hip resurfacings with 
evidence of a pseudotumour? 
 
Abstract  
 
Background 
The role of radiographs in the follow-up of metal-on-metal hip resurfacing (MoMHR) 
patients is unclear. We investigated whether a combination of patient and radiological factors 
predicted MoMHRs with evidence of a pseudotumour. 
 
Methods 
We performed a retrospective single-centre case-control study (384 MoMHRs). The 
pseudotumour group (n=130) all had symptomatic pseudotumours on cross-sectional imaging 
with the diagnosis confirmed at revision. The non-pseudotumour group (n=254; subgroup 
previously reported on) had normal cross-sectional imaging. Radiographs immediately prior 
to revision were assessed in the pseudotumour group and compared with radiographs 
performed at the time of normal cross-sectional imaging in the non-pseudotumour group. 
Two blinded independent observers analysed radiographs for signs of failure (excellent inter-
observer agreement). Logistic regression modeling identified patient and radiological 
predictors of pseudotumour revision.  
 
Results 
Pseudotumour hips more commonly had abnormal radiographs (80.0% vs. 63.4%; p=0.001). 
Patient and radiological factors predicting pseudotumour revision in the multivariable model 
were: female gender (odds ratio (OR) 3.14 (95% CI 1.85-5.35); p<0.001), high inclination 
Revised Manuscript (Maximum 3200 Words incl. Abstract)
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(OR 1.04 per degree (95% CI 1.01-1.07); p=0.006), acetabular osteolysis (OR 5.06 (95% CI 
2.14-12.0); p<0.001), femoral osteolysis (OR 17.8 (95% CI 5.09-62.2); p<0.001), and 
acetabular loosening (OR 3.35 (95% CI 1.34-8.35); p=0.009). Factors predicting being in the 
non-pseudotumour group were: anteversion >5o (5o to <10o: OR 0.31 (95% CI 0.12-0.77), 
p=0.012; >10o: OR=0.32 (95% CI 0.15-0.70), p=0.004) and heterotopic ossification (OR 
0.19 (95% CI 0.05-0.72); p=0.015). The model was well calibrated (p=0.589) with good 
discriminatory ability (area under the curve (AUC)=0.801; sensitivity=74.4%, 
specificity=71.7%).  
 
Conclusions 
A combination of patient and radiological factors provided useful information for 
distinguishing between MoMHRs with and without evidence of pseudotumours. Surgeons 
may wish to consider these specific patient and radiological factors before proceeding with 
cross-sectional imaging. Radiographs are important when assessing MoMHR patients and 
should be included in all follow-up protocols.  
 
Level of Evidence 
Diagnostic Study (Level III)   
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Introduction 
High short-term failure rates are reported for most metal-on-metal hip resurfacing (MoMHR) 
designs,1-3 with many revisions performed for pseudotumours.4,5 In an attempt to identify 
pseudotumours early, worldwide regulatory authorities recommend regular surveillance for 
most MoMHR patients.6-8  
 
Radiographs are considered important when assessing MoMHR patients, providing 
information on component position, bone quality, and implant fixation.9 Radiographs can 
identify signs suggestive of implant failure early, and in addition to blood metal ions and 
cross-sectional imaging, radiographs are currently recommended by most,7,8 but not all6 
regulatory authorities. However, given that pseudotumours can be solid or cystic lesions 
associated with soft tissue damage and high wear,4,5 clinicians prefer performing blood metal 
ions and cross-sectional imaging over radiographs.6-8 Previous studies have reported 
radiological risk factors for pseudotumours that include implanting acetabular components 
outside an “optimal zone”10-12 and significant reduction in the head-neck ratio following 
MoMHR.13 However, these studies are limited by small numbers of pseudotumour revisions, 
and assessing relatively few radiological parameters.10-13 Interpretation is also complicated by 
observations that pseudotumours can still occur in optimally positioned MoMHRs.11,14 
Furthermore, it remains unclear whether femoral neck narrowing is a normal “physiological” 
process following MoMHR or a clinically significant finding, given that neck narrowing is 
reported in both well-functioning MoMHRs15,16 and pseudotumour revisions.9,17 
 
The use of radiographs in the follow-up of MoMHR patients therefore remains unclear. 
However, it is important to establish the role of radiographs in MoMHR surveillance given 
 4 
their wide availability, low costs, and the fact that current follow-up recommendations are not 
evidence-based but very costly.18   
 
We investigated whether a combination of patient and radiological factors predicted 
MoMHRs with evidence of a pseudotumour. Using the factors identified, a clinical risk 
scoring tool was developed to predict a patient’s risk of having a pseudotumour. 
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Patients and Methods 
We performed a retrospective single-centre multi-surgeon case-control study including 384 
MoMHRs implanted in 329 patients (Table 1). These hips were divided into pseudotumour 
(case) and non-pseudotumour (control) groups. All primary MoMHRs were performed 
between June 1999 and December 2009. During this interval 1,429 MoMHRs in 1,216 
patients were implanted, with the outcomes for these patients previously described in detail.19 
 
Pseudotumour group (130 hips) 
Revision surgery of MoMHRs for pseudotumour has been performed since 2007 when this 
entity was first recognised.4 By August 2015, 231 consecutive MoMHR revisions for any 
indication were recorded in our prospective clinical database. The pseudotumour group for 
the present study included all MoMHRs revised for pseudotumour (n=130; 56% of all 
revisions). All patients undergoing revision for pseudotumour were symptomatic. Of the 130 
hips revised for pseudotumour, 111 (85%) had their MoMHR at our institution with the 
remainder being referred to our centre after undergoing primary arthroplasty elsewhere. Prior 
to revision surgery patients were investigated using anteroposterior (AP) pelvic radiographs, 
blood metal ions, and ultrasound, with metal artefact reduction sequence magnetic resonance 
imaging (MARS-MRI) reserved for equivocal or complex cases.4,20 The decision to perform 
revision was made by the patients’ surgeon based on their symptoms and investigative 
findings.  
 
All pseudotumours were diagnosed on cross-sectional imaging prior to revision surgery and 
subsequently confirmed intra-operatively. Pseudotumours were defined as cystic, solid, or 
mixed masses communicating with the hip joint.4,21,22 The diagnosis of a pseudotumour was 
confirmed if there was also histological evidence of lymphocytic infiltrates (including aseptic 
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lymphocytic vasculitis and associated lesions) and a phagocytic macrophage response to 
metal wear debris, with or without tissue necrosis.23-25   
 
Non-pseudotumour group (254 hips) 
Following alerts in 2010 and 2012 from the Medical and Healthcare Products Regulatory 
Agency (MHRA), all symptomatic MoMHR patients underwent investigation with AP pelvic 
radiographs, blood metal ions, and cross-sectional imaging.6,26 Prior to these alerts (in 
2007/2008) we had investigated 201 asymptomatic MoMHRs with AP pelvic radiographs, 
blood metal ions, and cross-sectional imaging.27 
 
The non-pseudotumour group for the present study included all non-revised MoMHR 
patients, regardless of symptoms, with normal cross-sectional imaging (no evidence of 
pseudotumours on ultrasound and/or MARS-MRI). The non-pseudotumour group included 
254 MoMHRs, of which 128 were symptomatic (median Oxford Hip Score28,29 (OHS)=32/48 
(inter-quartile range=24-38)) and 126 were asymptomatic (median OHS=47/48 (inter-quartile 
range=45-48)). The asymptomatic patient subgroup has previously been reported on.27 
 
Radiological analysis 
Standardised AP pelvic radiographs for all patients were accessed using the hospitals’ 
electronic picture archiving and communication system (PACS, GE Healthcare, Barrington, 
Illinois, USA). Apart from femoral neck narrowing (which also required the radiograph 
immediately following MoMHR), all radiological parameters were assessed using one single 
radiograph for each MoMHR. For the pseudotumour group the radiograph selected for 
assessment was the one performed closest to but immediately before the date of revision 
surgery. This represented a time when the hip was symptomatic and the pseudotumour had 
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already been diagnosed on cross-sectional imaging. In the non-pseudotumour group the 
radiograph selected for assessment was performed at the time cross-sectional imaging 
excluded a pseudotumour.  
 
Each radiograph was systematically analysed for the presence or absence of abnormalities 
previously described in MoMHRs including component loosening (radiolucent line >2mm in 
any zone), osteolysis, femoral neck notching, fracture, dislocation, subluxation, impingement, 
and heterotopic ossification (HO).9,30-32 Acetabular component inclination (relative to the 
pelvic interteardrop line) and anteversion were measured using ImageJ (National Institutes of 
Health, Berthesda, Maryland, USA).33 Acetabular components were considered 
malpositioned if one or both parameters were outside the recommended optimal zone for 
MoMHR (inclination 35o-55o /anteversion 10o-30o).11 Femoral neck narrowing was assessed 
as previously described.34 Femoral neck diameter was measured in each radiograph at the 
junction of the neck and femoral component, and divided by the measured femoral 
component diameter (allowing correction for magnification). The difference between 
measurements from the most recent radiograph and the radiograph immediately following 
MoMHR allowed calculation of the degree of femoral neck narrowing since index surgery 
(expressed as a percentage of the initial neck diameter).  
 
All radiographs were assessed by two independent observers (GSM and KD) in a random 
sequence, with both blinded to all clinical information including the study group. For the 
presence or absence of different radiographic abnormalities inter-observer agreement was 
almost perfect (Cohen’s kappa statistic ranging from 0.88-1.00).35 Any discrepancy regarding 
the presence or absence of abnormalities was settled by the senior author (HGP) with their 
final assessment used for analyses. For continuous radiographic data intra-class correlation 
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coefficients between observers were excellent: inclination=0.979 (95% confidence intervals 
(CI) 0.955-0.990), anteversion=0.968 (95% CI 0.947-0.988), femoral neck narrowing=0.941 
(95% CI 0.861-0.987). The mean of the two observer measurements were used for 
continuous radiographic variables. 
 
Statistical analysis  
The study outcome of interest was a binary variable: MoMHR with or without a 
pseudotumour. The influence of patient (gender, age, implant design) and radiographic 
factors (above) were assessed between groups. Numerical data were compared between 
groups using either unpaired t-tests (parametric data) or the Wilcoxon rank-sum test (non-
parametric data), with categorical data compared using either the Chi-squared test with 
Yates’ correction or Fisher’s exact test. 
 
Logistic regression modeling was used to identify predictors of outcome. Univariable models 
explored the association between each predictor and outcome. For continuous predictors 
linearity was assessed using likelihood ratio tests, with data categorised if the relationship 
between a predictor and the outcome was non-linear. A multivariable logistic regression 
model was formulated using backward selection, with patient and radiographic predictors 
retained in the final model if p<0.10. Regression diagnostics were assessed to ensure all 
assumptions underlying the model were met.36,37 
 
Internal validation of the final multivariable model was performed, including calibration, 
discrimination, and bootstrapping (Appendix).37-39 Patient and radiographic factors from the 
final multivariable model were formulated into a clinical risk scoring tool with each factor 
assigned a weighting based on its respective regression coefficient.38,40 The calculated overall 
 9 
score represents a patient’s risk of having evidence of a pseudotumour, with higher scores 
associated with increased risk (Appendix). P-values <0.05 were considered statistically 
significant. 
 
Source of funding 
The Royal College of Surgeons of England and Arthritis Research UK. 
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Results 
 
Patient factors (Table 1) 
Compared to the non-pseudotumour group, the pseudotumour group were younger 
(p=0.0286), more commonly female (63.9% vs. 38.2%; p<0.001), and had a longer follow-up 
time (mean 5.8 years vs. 4.8 years; p<0.001). There were significant differences in MoMHR 
implant design (p=0.022) between groups.  
 
Radiographic factors (Table 2) 
The pseudotumour group was significantly more likely to have radiographic abnormalities 
compared to the non-pseudotumour group (80.0% vs. 63.4%; p=0.001). Abnormalities more 
frequently observed in the pseudotumour group were: acetabular (21.5% vs. 4.3%; p<0.001) 
and femoral (20.0% vs. 1.6%; p<0.001) osteolysis, acetabular component loosening (13.1% 
vs. 4.7%; p=0.003), higher acetabular inclination (mean 49.5o vs. 46.0o; p=0.0013), femoral 
fracture (p=0.013), dislocation (p=0.038), and subluxation (p=0.038). Acetabular component 
anteversion (p=0.697) and femoral neck narrowing (p=0.556) were not different between 
groups. The non-pseudotumour group was significantly more likely to have HO compared to 
the pseudotumour group (15.8% vs. 2.3%; p<0.001).  
 
Logistic regression (Table 3)  
Five factors (female gender; high acetabular component inclination; acetabular osteolysis; 
femoral osteolysis; acetabular component loosening) significantly predicted being in the 
pseudotumour group in both the univariable and multivariable logistic regression analysis, 
and two factors (acetabular component anteversion >5o; HO) significantly predicting being in 
the non-pseudotumour group. Young age at radiograph (p=0.044) was a significant predictor 
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of being in the pseudotumour group in the univariable analysis, though was not significant in 
the multivariable analysis. 
 
Internal validation of final multivariable model 
The final multivariable model was well calibrated (p=0.589; Figure 1), and demonstrated 
good discriminatory ability with an AUC of 0.801 (95% CI 0.752-0.849; sensitivity=74.4%, 
specificity=71.7%; Figure 2). Bootstrap validation of the final model provided a bias-
corrected AUC of 0.784.  
 
Clinical risk scoring tool (Table 4) 
A clinical points-based risk tool for identifying patients with evidence of a pseudotumour was 
developed using the final multivariable model. High overall scores represented an increased 
pseudotumour risk. Validation of the overall risk score model demonstrated it had good 
discriminatory ability (AUC=0.796; 95% CI 0.747-0.845). The optimal risk score threshold 
for identifying MoMHRs with evidence of pseudotumours was 18-points or more (95% CI 
11.9-24.1), which had 80.8% sensitivity and 65.2% specificity. 
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Discussion 
The present large study demonstrated that a combination of patient and radiological factors 
provided useful information for distinguishing between MoMHRs with and without evidence 
of pseudotumours. Patient and radiographic factors predictive of MoMHRs with evidence of 
a pseudotumour included female gender, acetabular component malposition, osteolysis and 
acetabular loosening. Surgeons may wish to consider these factors before proceeding with 
cross-sectional imaging.   
 
Our findings suggest radiographs form an important part of the assessment of MoMHR 
patients. The high AUC of the final model (0.801, and bias-corrected=0.784) confirms a 
combination of patient and radiographic factors were useful for distinguishing between 
MoMHRs with and without evidence of pseudotumours. Previous studies are limited by only 
assessing a few radiological factors, such as cup position or neck narrowing.10-13,34 By 
contrast the current study assessed all major radiological parameters, and is further 
strengthened by having a large control group including both symptomatic and asymptomatic 
patients with no cross-sectional imaging evidence of pseudotumours. These non-revised 
MoMHR patients are typical of the many currently under regular surveillance worldwide.18 
 
The final multivariable model identified female gender as the only patient factor significantly 
predicting MoMHRs with evidence of a pseudotumour. This finding is consistent with the 
literature1,2,12,41 and further highlights the importance of stratifying MoMHR patients by 
gender for surveillance.18,42 Although it is recognised that certain MoMHR designs have 
higher failure rates,1,2,12 the present study did not identify implant design as a significant 
predictor of pseudotumour revision. This may reflect the limited different implant designs 
and small numbers of certain implant designs included in the present study. However, we 
 13 
agree with previous recommendations that it is important to consider implant design when 
making clinical decisions about MoMHR patients.18,42 
 
Similar to previous studies10-12 we identified high inclination and inadequate anteversion 
(<5o) as predictors of pseudotumour revision. Hard-on-hard bearings have low tolerances to 
acetabular component positioning outside an “optimal zone,” with such malposition 
associated with edge loading, high bearing wear, and early failure.11 However the relationship 
between acetabular component position and pseudotumours is complex. Our study and two 
others observed MoMHRs revised for pseudotumour more commonly have acetabular 
components positioned in inadequate anteversion,10,11 though it is recognised other cohorts 
report excessive anteversion to be more important.12 In addition, pseudotumours in patients 
with adequately positioned acetabular components have been reported in both our study (46% 
of pseudotumour group; Table 2) and previously.11,12,43 Furthermore, a number of well-
functioning MoMHR patients have malpositioned acetabular components.15,16,44,45 Although 
63% of our non-pseudotumour group had abnormal radiographs, which appears high, 
acetabular component malposition was the primary reason for these abnormalities. When all 
radiographic abnormalities apart from malposition were considered, only 19% of our non-
pseudotumour group had abnormal radiographs. Other studies have similarly reported 
abnormal radiographs (excluding malposition) in up to 25% of non-revised 
MoMHRs.15,16,44,45 These observations suggest pseudotumour development is multifactorial 
and not solely dependent on acetabular component malposition. It is therefore important to 
assess radiographs for other signs suggestive of failure.   
 
Osteolysis (femoral and acetabular) and acetabular component loosening were highly 
predictive of MoMHRs with pseudotumours in this study. Previous reports observed intra-
 14 
operative osteolysis in up to 33% of pseudotumour revisions, and acetabular loosening in up 
to 28%.17,46 Furthermore, extensive osteolysis can require complex reconstruction, which 
may contribute to poor short-term outcomes following pseudotumour revision.20,47,48 
Surgeons must therefore carefully inspect MoMHR radiographs for subtle osteolysis or 
acetabular loosening and arrange further investigations were necessary, as early identification 
of pseudotumours may improve patient outcomes following revision. 
 
The clinical significance of femoral neck narrowing remains unclear. In well-functioning 
MoMHRs narrowing has been observed in up to 77% of cases, with up to 28% having greater 
than 10% narrowing.15,16,30,34 Longitudinal studies report that neck narrowing stabilises in 
well-functioning MoMHR patients within 5 years.16,30,34 Therefore it has been suggested that 
neck narrowing is a normal process reflecting early bone remodeling.13,15 However, neck 
narrowing has also been reported in up to 26% of MoMHRs revised for pseudotumour.9,17 
We observed similar degrees of neck narrowing in MoMHRs with and without 
pseudotumours. This suggests femoral neck narrowing does not necessarily represent an 
underlying pseudotumour. However, if narrowing is observed it must be interpreted in the 
context of other abnormalities. 
 
Radiographic HO was more common in MoMHRs without evidence of pseudotumours. The 
HO rate in the non-pseudotumour group (15.8%) was much lower than previous observations 
(up to 59%).49 As HO is more common in males,49 we suspect the higher rates observed in 
our non-pseudotumour group are related to significantly more males having well-functioning 
MoMHRs.15,16,41 It is recognised other factors may also contribute to differences in HO rates, 
including surgical approach and drug use during the post-operative period. However these 
factors were not assessed due to lack of medication data and the risk of overfitting our 
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multivariable model. It is possible that patients with HO have a lower pseudotumour risk 
because the associated stiffness and reduced hip motion may decrease the risk of edge 
loading and subsequent pseudotumour formation, however this requires further investigation. 
 
Current worldwide follow-up recommendations for MoMHR patients have recently been 
reported not to be evidence-based but very costly.18 The use of radiographs during follow-up 
has been somewhat overlooked because of blood metal ions and cross-sectional imaging,18 
with some authorities not even specifying a role for radiographs.6 The final study model and 
clinical risk scoring tool contained relevant patient and radiological factors which were useful 
for distinguishing between MoMHRs with and without evidence of pseudotumours. Our 
study therefore demonstrates that radiographs comprise an important part of the assessment 
of MoMHR patients, and we recommend all regulatory authorities include radiographs in 
their follow-up recommendations. Our findings may be particularly useful in centres where 
follow-up resources must be rationed given the costly nature of MoMHR surveillance,18 and 
in centres where access to blood metal ion analysis and cross-sectional imaging is limited. 
However, radiographs should not be considered a substitute for performing blood metal ions 
and cross-sectional imaging, given 20% of our revisions had normal radiographs despite 
having histologically confirmed pseudotumours. Furthermore, our findings require validation 
prior to any clinical implementation.50   
 
This study has limitations, such as being retrospective and potentially not applicable to other 
MoMHR designs. Furthermore, the radiographs assessed in the pseudotumour group were 
performed significantly later from primary MoMHR compared to non-pseudotumour 
patients, which should be considered when interpreting our findings. Given limitations with 
radiographic data (49% of MoMHRs had adequate quality immediate post-operative 
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radiographs), this study cannot make conclusive statements about femoral neck narrowing. It 
is important to also acknowledge that this study only predicts the presence or absence of a 
pseudotumour at the time of radiographic assessment, and not the subsequent development of 
a pseudotumour which would require a longitudinal study. Our final model requires 
validation in an external cohort, however robust internal validation techniques were 
employed and the final model was not overfitted. 
 
Conclusions 
A combination of patient and radiological factors provided useful information for 
distinguishing between MoMHRs with and without evidence of pseudotumours. Surgeons 
may wish to consider these patient and radiological factors predictive of pseudotumour 
(including female gender, acetabular component malposition, osteolysis, and acetabular 
loosening) before proceeding with cross-sectional imaging. Radiographs are important when 
assessing MoMHR patients and should be included in the follow-up recommendations issued 
by all regulatory authorities. 
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Figure Legends 
 
Figure 1 Plot to assess calibration of the final multivariable model 
Calibration measures how closely predicted risk (obtained from the final multivariable 
model) agrees with observed risk (0=non-pseudotumour group; 1=pseudotumour group). 
Calibration was assessed for each tenth of predicted risk using 10 equally sized groups. For 
each of the 10 groups the predicted risk was plotted against the mean observed risk for that 
particular group. The ‘ideal’ model has a line with a slope of 1 going through the graph 
origin. The ‘apparent’ line represents our final multivariable model and shows the model was 
well calibrated throughout the complete range of pseudotumour risk. The ‘bias-corrected’ 
line was obtained from 200 bootstrap repetitions to internally validate our model. The ‘bias-
corrected’ line closely follows the ‘apparent’ line for our final multivariable model.  
 
Figure 2 Receiver operating characteristic (ROC) curve to assess discrimination of the final 
multivariable model for identifying patients with evidence of a pseudotumour 
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question) question) 
 
XXI. Does this question have an image or images? 
☐ Yes                                      ☒ No  
(If YES – upload image(s) separately using the ”CME Question Figure” item option in the Attach Files 
screen of Editorial Manager. Include a one to two sentence description of each figure here. All figures 
should be at least 5x7 inches with a resolution of 300 ppi.) 
 
XXII. Question:  (A patient-care scenario is preferred when appropriate; see Guidelines) 
Which of the following radiological factors was a significant predictor of metal-on-metal hip 
resurfacings with evidence of pseudotumours? 
 
 
 
XXIII. Options: ( in alphabetical or logical order) 
 
A. Femoral notching 
B.  Femoral neck narrowing 
C. Heterotopic ossification 
D. Acetabular component retroversion  
E.  Acetabular osteolysis 
 
XXIV. Answer: (must be clearly the best of the options) 
☐ A.  ☐ B.  ☐ C.  ☐ D.  ☒ E. 
 
VII. Answer Location: Please list the heading of the manuscript section where the correct answer 
is located (e.g. “Results” or “Anatomy and Physiology”).  
 
 
 
VIII. Core Competencies addressed by this CME question: 
 ☐ Patient Care: Provide care that is compassionate, appropriate, and effective 
treatment for health problems and to promote health. 
☒ Medical  
     Knowledge:   
Demonstrate knowledge about established and evolving biomedical, 
clinical, and cognate sciences and their application in patient care. 
☐ Practice-Based 
Learning and 
Show and ability to Investigate and evaluate patient care practices, 
appraise and assimilate scientific evidence, and improve the practice 
Results 
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Improvement: of medicine. 
☐ Interpersonal and 
    Communication  
    Skills:  
Demonstrate skills that result in effective information exchanges and 
teaming with patients, their families and professional associates (e.g. 
fostering a therapeutic relationship that is ethically sound, used 
effective listening skills with non-verbal and verbal communication; 
working as both a team member and at times a leader). 
☐ Professionalism:  Demonstrate a commitment to carrying out professional 
responsibilities, adherence to ethical principles, and sensitivity to a 
diverse patient population. 
☐ Systems-Based 
     Practice: 
Demonstrate awareness of and responsiveness to the larger context 
and systems of health care. Be able to call on system resources to 
provide optical care (e.g. coordinating care across sites or serving as 
the primary case manager when care involves multiple specialties, 
professions or sites). 
 
 
Question 5      (staff use only – question type_____) 
 
XXV. Question Category:  Check as many categories as seem appropriate. Question category may 
differ from manuscript category. 
 
☐ Basic science 
☐ Ethics  
☐ Elbow 
☐ Foot and ankle 
☐ Hand and wrist 
☒ Hip reconstruction, 
adult 
☐ Infection 
☐ Knee reconstruction, adult 
☐ Oncology 
☐ Pain management  
☐ Pediatrics  
☐ Rehabilitation  
☐ Shoulder 
☐ Spine 
☐ Sports  
☐ Trauma 
☐ General interest/Does not fit 
any other category 
 
XXVI. Intended Audience: Check as many categories as seem appropriate. 
 
☐ Allied health 
personnel (minimum 
of one question) 
☒MD, non-
orthopaedic 
(minimum of one 
question) 
☒ Orthopaedic 
generalist 
(minimum of one 
question) 
☒ Orthopaedic 
subspecialist (minimum 
of one question) 
 
XXVII. Does this question have an image or images? 
☐ Yes                                      ☒ No  
(If YES – upload image(s) separately using the ”CME Question Figure” item option in the Attach Files 
screen of Editorial Manager. Include a one to two sentence description of each figure here. All figures 
should be at least 5x7 inches with a resolution of 300 ppi.) 
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XXVIII. Question:  (A patient-care scenario is preferred when appropriate; see Guidelines) 
Which of the following radiological factors was a significant predictor of metal-on-metal hip 
resurfacings with no evidence of pseudotumours? 
 
 
 
XXIX. Options: ( in alphabetical or logical order) 
 
A. Heterotopic ossification 
B.  Femoral loosening 
C. Femoral neck narrowing 
D. Femoral notching 
E.  Impingement  
 
XXX. Answer: (must be clearly the best of the options) 
☒ A.  ☐ B.  ☐ C.  ☐ D.  ☐ E. 
 
VII. Answer Location: Please list the heading of the manuscript section where the correct answer 
is located (e.g. “Results” or “Anatomy and Physiology”).  
 
 
 
VIII. Core Competencies addressed by this CME question: 
 ☐ Patient Care: Provide care that is compassionate, appropriate, and effective 
treatment for health problems and to promote health. 
☒ Medical  
     Knowledge:   
Demonstrate knowledge about established and evolving biomedical, 
clinical, and cognate sciences and their application in patient care. 
☐ Practice-Based 
Learning and 
Improvement: 
Show and ability to Investigate and evaluate patient care practices, 
appraise and assimilate scientific evidence, and improve the practice 
of medicine. 
☐ Interpersonal and 
    Communication  
    Skills:  
Demonstrate skills that result in effective information exchanges and 
teaming with patients, their families and professional associates (e.g. 
fostering a therapeutic relationship that is ethically sound, used 
effective listening skills with non-verbal and verbal communication; 
working as both a team member and at times a leader). 
☐ Professionalism:  Demonstrate a commitment to carrying out professional 
responsibilities, adherence to ethical principles, and sensitivity to a 
Results 
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diverse patient population. 
☐ Systems-Based 
     Practice: 
Demonstrate awareness of and responsiveness to the larger context 
and systems of health care. Be able to call on system resources to 
provide optical care (e.g. coordinating care across sites or serving as 
the primary case manager when care involves multiple specialties, 
professions or sites). 
 
 
Table 1 Patient demographics for all metal-on-metal hip resurfacings (n=384) 
 
Co-variate All hips 
(n=384; 100%) 
Non-
pseudotumour 
group 
(n=254; 66.1%) 
Pseudotumour 
group 
(n=130; 33.9%) 
p-value 
Gender 
Male 
Female 
 
204 (53.1) 
180 (46.9) 
 
 
  157 (61.8) 
97 (38.2) 
 
47 (36.2) 
83 (63.9) 
 
<0.001 
Mean age at x-ray 
(range) in years 
59.4 
(30.3-88.2) 
 
60.2 
(30.3-88.2) 
 
58.0 
(37.5-77.6) 
 
0.0286 
Mean time from 
primary to x-ray 
(range) in years 
 
5.1 
(0.25-15.1) 
4.8 
(2.0-15.1) 
5.8 
(0.25-14.1) 
<0.001 
Mean time from 
primary to revision 
(range) in years 
 
NA NA 6.3 
(0.31-14.8) 
NA 
Primary Implant 
BHR 
Conserve 
Recap 
Cormet 
 
 
180 (46.9) 
174 (45.3) 
26 (6.8) 
4 (1.0) 
 
 
117 (46.1) 
122 (48.0) 
15 (5.9) 
0 (0) 
 
 
63 (48.5) 
52 (40.0) 
11 (8.5)   
4 (3.1) 
 
 
0.022 
Median blood metal 
ion concentrations 
(IQR) in µg/l 
Cobalt 
Chromium 
 
 
 
2.2 (1.5-4.6) 
2.4 (1.3-4.9) 
 
 
 
 
2.1 (1.4-3.6) 
2.2 (1.3-4.1) 
 
 
 
 
6.3 (3.1-22.5) 
7.6 (2.6-29.2) 
 
 
 
 
<0.0001 
<0.0001 
 
BHR = Birmingham Hip Resurfacing; IQR = inter-quartile range; NA=Not applicable 
 
Statistically significant results (p<0.05) highlighted in bold text 
 
 
 
 
 
 
 
 
 
 
 
Table 1
Table 2 Radiological features for all metal-on-metal hip resurfacings (n=384) 
 
Co-variate All hips 
(n=384; 
100%) 
Non-
pseudotumour 
group 
(n=254; 66.1%) 
Pseudotumour 
group 
(n=130; 33.9%) 
p-value 
Abnormal radiograph 
(>1 abnormality) 
Normal radiograph   
 
265 (69.0%) 
 
119 (31.0%) 
161 (63.4%) 
 
93 (36.6%) 
104 (80.0%) 
 
26 (20.0%) 
0.001 
Cup position 
Mean inclination in o 
(range) 
 
Mean anteversion in o 
(range) 
 
Malpositioned* 
 
 
47.2 
(21.3-83.5) 
 
14.9 
(1.2-40.3) 
 
183 (47.7%) 
 
 
46.0 
(21.3-67.6) 
 
14.7 
(1.2-40.3) 
 
113 (44.5%) 
 
49.5 
(24.3-83.5) 
 
15.1 
(1.2-39.5) 
 
70 (53.8%) 
 
0.0013 
 
 
0.697 
 
 
0.062 
Femoral neck 
narrowing 
Mean narrowing 
(range) 
 
>10% narrowing 
 
 
 
4.7% 
(0.3%-22.2%) 
 
13 (3.4%) 
 
 
4.5% 
(0.3%-22.2%) 
 
7 (2.8%) 
 
 
5.0% 
(0.3%-17.4%) 
 
6 (4.6%) 
 
 
0.556 
 
 
0.377 
Osteolysis 
Acetabular 
Femoral 
 
 
39 (10.2) 
30 (7.8) 
 
11 (4.3) 
  4 (1.6) 
 
28 (21.5) 
26 (20.0) 
 
<0.001 
<0.001 
 Loosening 
Acetabular 
Femoral 
 
 
29 (7.6) 
13 (3.4) 
 
12 (4.7) 
7 (2.8) 
 
17 (13.1) 
6 (4.6) 
 
0.003 
0.377 
Heterotopic 
ossification 
43 (11.2) 40 (15.8) 3 (2.3) <0.001 
Femoral neck 
notching  
12 (3.1) 
 
9 (3.5) 3 (2.3) 0.758 
Fracture 
Acetabular 
Femoral 
 
0 (0) 
4 (1.0) 
 
0 (0) 
0 (0) 
 
0 (0) 
4 (3.1) 
 
NA 
0.013 
Dislocation  3 (0.78) 
 
0 (0) 
 
3 (2.3) 0.038 
Subluxation 3 (0.78) 
 
0 (0) 
 
3 (2.3) 0.038 
Impingement 0 (0) 0 (0) 0 (0) NA 
NA = not applicable 
* Malposition was defined as one or both parameters outside the previously recommended 
optimal zone (inclination 35o-55o and anteversion 10o-30o).11  
Statistically significant results (p<0.05) highlighted in bold text 
Table 2
Table 3 Logistic regression models identifying patient and radiographic factors predictive of 
pseudotumour revision 
Co-variate Univariable 
model       
Odds Ratio 
(95% CI) 
p-value Final 
multivariable  
model       
Odds Ratio 
(95% CI) 
p-
value 
Gender 
Male 
Female 
 
1.00 
3.00 (1.92-4.68) 
 
 
<0.001 
 
1.00 
3.14 (1.85-5.35) 
 
<0.001 
Age at radiograph (per 
year) 
 
0.98 (0.95-1.00) 
 
0.044 
 
*  
Primary Implant 
BHR 
Conserve 
Other (Recap and Cormet) 
 
1.00 
0.79 (0.50-1.25) 
1.89 (0.86-4.11) 
 
 
0.309 
0.111 
 
 
* 
 
 
 
 
Cup position 
Inclination (per degree)  
 
Anteversion 
<5o 
5o to <10o 
>10o 
 
 
1.04 (1.02-1.07) 
 
 
1.00 
0.37 (0.17-0.82) 
0.49 (0.25-0.94) 
 
 
0.001 
 
 
 
0.014 
0.033 
 
1.04 (1.01-1.07) 
 
 
1.00 
0.31 (0.12-0.77) 
0.32 (0.15-0.70) 
 
0.006 
 
 
 
0.012 
0.004 
 
Femoral neck narrowing 
 
1.03 (0.98-1.08) 
 
0.259 *  
Osteolysis 
Acetabular 
Femoral 
 
 
5.91 (2.82-12.4) 
14.4 (4.88-42.7) 
 
<0.001 
<0.001 
 
5.06 (2.14-12.0) 
17.8 (5.09-62.2) 
 
<0.001 
<0.001 
 Loosening 
Acetabular 
Femoral 
 
 
3.15 (1.41-7.01) 
1.73 (0.57-5.26) 
 
0.005 
0.335 
 
3.35 (1.34-8.35) 
* 
 
0.009 
Heterotopic ossification 0.13 (0.039-0.42) 
 
0.001 0.19 (0.05-0.72) 0.015 
Femoral neck notching  0.65 (0.17-2.45) 
 
0.524 *  
Femoral fracture 1 NA *  
Dislocation  1 NA *  
Subluxation 1 NA *  
BHR = Birmingham Hip Resurfacing; CI = confidence interval; NA = not applicable 
 
*Final multivariable logistic regression model only includes patient and radiological factors 
where p<0.10.  
Table 3
 Statistically significant results (p<0.05) highlighted in bold text 
 
Impingement and acetabular fracture were not analysed as no events occurred in the whole 
cohort 
 
The affect of acetabular component anteversion (p-value for non-linearity=0.0144) on 
outcome was non-linear, therefore this co-variate was categorised. The affect of both patient 
age at radiograph (p-value for non-linearity=0.937) and acetabular component inclination (p-
value for non-linearity=1.0) on outcome were linear, therefore these co-variates were 
analysed as continuous variables. 
Table 4 Clinical risk scoring tool for determining pseudotumour risk based on patient and 
radiological factors 
Co-variate Regression coefficient from 
final multivariable model 
 
Risk score 
Gender 
Male 
Female 
 
Reference group 
1.14  
 
0 
11 
 
Cup position 
Inclination  
20o to <30o 
30o to <40o 
40o to <50o 
50o to <60o 
60o to <70o 
70o to <80o 
80o to <90o 
 
Anteversion 
<5o 
5o to <10o 
>10o 
 
 
.041 
Reference group 
 
 
 
 
 
 
 
 
Reference group 
-1.18 
-1.13   
 
 
 
0 
14 
18 
23 
27 
31 
35 
 
 
0 
-12 
-11 
Acetabular osteolysis 
No 
Yes 
 
 
Reference group 
1.62  
 
 
0 
16 
Femoral osteolysis 
No 
Yes 
 
 
Reference group 
2.88 
 
 
0 
29 
Acetabular loosening 
No 
Yes 
 
 
Reference group 
1.21 
 
0 
12 
Heterotopic ossification 
No 
Yes 
 
 
Reference group 
-1.64 
 
0 
-16 
 
All baseline/reference groups for each category have a risk score of zero 
 
Higher scores indicate increased risk of pseudotumour 
 
 
 
 
Table 4
Figure 1 Click here to download Figure Figure 1 - Model calibration.tif 
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Appendix Detailed statistical methods 
 
1. Internal validation of the final multivariable model 
Robust internal validation of the final multivariable model was performed using calibration, 
discrimination, and bootstrapping techniques.37-39 Calibration measures how closely predicted 
risk agrees with observed risk. Calibration was assessed for each tenth of predicted risk using 
10 equally sized groups, with a Hosmer-Lemeshow goodness-of-fit test performed to 
quantify calibration (non-significant p-value indicates a well calibrated model). 
Discrimination is the models ability to differentiate between MoMHRs with and without 
evidence of a pseudotumour, which is assessed by calculating the area under the receiver 
operating characteristic curve (AUC). The AUC for a useful prognostic model is between 
0.60-0.85.38 The final multivariable regression model was further validated using 
bootstrapping with backward stepwise variable deletion.37 Two-hundred bootstrap repetitions 
were performed to obtain a bias-corrected estimate of the AUC using a modified dataset.  
 
2. Developing a clinical risk scoring tool 
Using the patient and radiological predictors included in the final multivariable logistic 
regression model a clinical risk scoring tool was developed using previously described 
methods.40 The calculated overall score represents a patients’ risk of having evidence of a 
pseudotumour, with higher scores associated with increased pseudotumour risk. The 
respective regression coefficient for each predictor from the final multivariable model was 
converted to an integer risk score. The reference group for all variables was assigned a risk 
score of zero. For all variables apart from inclination the risk scores for non-reference groups 
were calculated by multiplying the respective regression coefficient by 10 and then rounding 
to the nearest whole number. Inclination data were grouped with the midpoint for each group 
Appendix
taken (midpoint of 30o to 39o group was 34.5o). The midpoint for non-reference inclination 
groups was then multiplied by the respective regression coefficient, multiplied by 10, and 
then rounded to the nearest whole number. The discriminatory ability of the final overall risk 
score was assessed by calculating the AUC. The optimal risk score threshold for identifying 
MoMHRs with evidence of a pseudotumour was also calculated.  
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Statement regarding need for ethical committee approval 
This study did not require ethical approval and a letter from our National Research Ethics 
Service is attached to confirm this. Furthermore, metal-on-metal hip resurfacing patients were 
reviewed as part of the institution’s routine follow-up arrangements, which have been 
adapted in response to published recommendations from the United Kingdom Medical and 
Healthcare Products Regulatory Agency (MHRA). Therefore no patients were specifically 
recalled for the study presented in the submitted manuscript, with all data obtained from the 
institution’s clinical and imaging databases and from medical records.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IRB Approval explanation
Nationa/ Research Ethics Seryrce
Oxfordshire REC G
2nd Floor, Astral House
chaucer'"H'ffi:;,ilX
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'F:Tffl[,31333 33i 333
20 March 2009 
Email: scsha'oxfordRECC@nhs'net
Hemant Pandit
c/o ooEc
C/O Botnar Research Centre,
Windmill Road,
Headington
Oxford OX3 7LD
Dear Hemant,
Full title of project: Prospective follow up of all hip and knee replacements.
Thank you for seeking the Committee's advice about the above project.
Following your discussion with the Chair, Janet Burton regarding the issue of regular
follow up of patients (after joint replacement - clinical and radiological), she advised
that the proposal is an audit. Therefore it does not require ethical review by a NHS
Research Ethics Committee.
You can find a copy of our leaflet, "Defining Research", which explains how we
differentiate research from other activities, at the following web address:
http:/iwww.nres.npsa.nhs. uk/rec-community/guidance/#researchoraudit.
You should check with the Oxford Radcliffe Hospitals NHS Trust what other review
arrangements or sources of advice apply to projects of this type. Guidance may be
available from the clinical governance office.
This letter should not be interpreted as giving a form of ethical approval to the project
or any endoi-semerit cf the project, but !t rnay be pro'.,ided to a jcur"nal or other body
as evidence that ethical approval is not required under NHS research governance
arrangements.
However, if you, your sponsor/funder or any NHS organisation feels that the project
should be managed as research and/or that ethical review by a NHS REC is
essential, please write setting out your reasons and we will be pleased to consider
further.
This Research Ethics Committee is an advisory committee to South Central Strategic Health Authority
The National Research Ethics Service (A/RFS) represe nts the NRES Directorate within
the National Patient Safety Agency and Research Ethics Cammittees in England.
IRB Approval letter
Where NHS organisations have clarified that a project is
research, the Research Governance Framework states
presented as research within the NHS.
Yours sincerely
Sabrina Harris
Com mittee Co-ordinator
not to be managed
that it should not
AS
be
This Research Ethics Committee is an advisory committee to South Central Strategic Health Authority
The National Research Ethics Service (NRES) represents the NRES Directorate within
the National Patient Safety Agency and Research Ethics Committees in England.
